| 000 | 01578 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515201028.0 | ||
| 264 | 0 | _c20100310 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1471-2369 | ||
| 024 | 7 |
_a10.1186/1471-2369-10-42 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRanganathan, Dwarakanathan | |
| 245 | 0 | 0 |
_aOptimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study. _h[electronic resource] |
| 260 |
_bBMC nephrology _cDec 2009 |
||
| 300 |
_a42 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGentamicins _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Parenteral |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeritoneal Dialysis _xadverse effects |
| 650 | 0 | 4 |
_aPeritonitis _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aVarghese, Julie M | |
| 700 | 1 | _aFassett, Robert G | |
| 700 | 1 | _aLipman, Jeffrey | |
| 700 | 1 | _aD'Intini, Vincent | |
| 700 | 1 | _aHealy, Helen | |
| 700 | 1 | _aRoberts, Jason A | |
| 773 | 0 |
_tBMC nephrology _gvol. 10 _gp. 42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2369-10-42 _zAvailable from publisher's website |
| 999 |
_c19385673 _d19385673 |
||